These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1037 related articles for article (PubMed ID: 9178866)
1. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. Pollack AE; Turgeon SM; Fink JS Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866 [TBL] [Abstract][Full Text] [Related]
2. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats. Pollack AE; Yates TM Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212 [TBL] [Abstract][Full Text] [Related]
3. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Pollack AE; Strauss JB Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705 [TBL] [Abstract][Full Text] [Related]
4. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Paul ML; Currie RW; Robertson HA Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877 [TBL] [Abstract][Full Text] [Related]
5. Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors. Fenu S; Morelli M Eur J Neurosci; 1998 May; 10(5):1878-84. PubMed ID: 9751157 [TBL] [Abstract][Full Text] [Related]
6. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Pollack AE; Thomas LI Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912 [TBL] [Abstract][Full Text] [Related]
7. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Paul ML; Graybiel AM; David JC; Robertson HA J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113 [TBL] [Abstract][Full Text] [Related]
8. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study. Hassani OK; Féger J Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602 [TBL] [Abstract][Full Text] [Related]
9. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707 [TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats. Pollack AE; Fink JS Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239 [TBL] [Abstract][Full Text] [Related]
11. NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats. Pollack AE; Haisley EC Brain Res; 2001 Apr; 897(1-2):213-6. PubMed ID: 11282380 [TBL] [Abstract][Full Text] [Related]
12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
13. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats. Pollack AE; St Martin JL; MacPherson AT Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Marshall JF; Cole BN; LaHoste GJ Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600 [TBL] [Abstract][Full Text] [Related]
15. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617 [TBL] [Abstract][Full Text] [Related]
16. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei. Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472 [TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Fenu S; Pinna A; Ongini E; Morelli M Eur J Pharmacol; 1997 Feb; 321(2):143-7. PubMed ID: 9063681 [TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
19. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Brus R; Kostrzewa RM; Nowak P; Perry KW; Kostrzewa JP Neurotox Res; 2003; 5(5):329-38. PubMed ID: 14715452 [TBL] [Abstract][Full Text] [Related]
20. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]